Sabra Health Care REIT, Inc.
Simbols: SBRA
NASDAQ
13.93
USDTirgus cena šodien
234.1496
P/E koeficients
-13.6793
PEG koeficients
3.22B
MRK Cap
- 0.09%
DIV ienesīgums
Sabra Health Care REIT, Inc. (SBRA) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 140.74 | 46.7 | 49.3 | 112 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 411.4 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 2116.51 | 496.6 | 559.3 | 537.2 | ||||||||||||||
balance-sheet.row.inventory | 172.54 | 46.7 | 411.4 | 119.8 | ||||||||||||||
balance-sheet.row.other-current-assets | -156.64 | -46.7 | -406.8 | -115.9 | ||||||||||||||
balance-sheet.row.total-current-assets | 2273.15 | 543.3 | 613.2 | 653.1 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18780.81 | 4628.9 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 684.9 | 213.6 | 135 | 96.7 | ||||||||||||||
balance-sheet.row.tax-assets | -18780.81 | -4628.9 | -4959.3 | -5162.9 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 18750.3 | 4598.3 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 19574.21 | 4842.9 | 5134.4 | 5313.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.account-payables | 121.86 | 0 | 142.3 | 143 | ||||||||||||||
balance-sheet.row.short-term-debt | 2082.36 | 196.6 | 197 | 1783.3 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 9271.41 | 2217.5 | 2506.8 | 2394.5 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | -1467.72 | 34.8 | -197 | -1783.3 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9519.49 | 2352.2 | 2549 | 2444.2 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 145.87 | 32.5 | 42.2 | 49.7 | ||||||||||||||
balance-sheet.row.total-liab | 10256 | 2583.6 | 2691.3 | 2587.2 | ||||||||||||||
balance-sheet.row.preferred-stock | 1685.51 | 20.5 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 9.25 | 2.3 | 2.3 | 2.3 | ||||||||||||||
balance-sheet.row.retained-earnings | -6494.47 | -1718.3 | -1451.9 | -1095.2 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 90.31 | 1 | 19.1 | -10 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 16300.75 | 4497.1 | 4487 | 4482.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 21847.35 | - | - | - | ||||||||||||||
Total Investments | 684.9 | 213.6 | 597.4 | 96.7 | ||||||||||||||
balance-sheet.row.total-debt | 9612.77 | 2446.6 | 2703.8 | 2394.5 | ||||||||||||||
balance-sheet.row.net-debt | 9472.03 | 2399.9 | 2654.4 | 2282.5 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
cash-flows.row.deferred-income-tax | -25.1 | 2.7 | 0 | 227.8 | ||||||||||||||
cash-flows.row.stock-based-compensation | 7.92 | 7.9 | 7.5 | 7.9 | ||||||||||||||
cash-flows.row.change-in-working-capital | -2.73 | -2.7 | -19.7 | 22.7 | ||||||||||||||
cash-flows.row.account-receivables | -11.08 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.inventory | -8.43 | 11.1 | 6.4 | -8.2 | ||||||||||||||
cash-flows.row.account-payables | 8.34 | 8.3 | -13.3 | 14.5 | ||||||||||||||
cash-flows.row.other-working-capital | 17.05 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 123.64 | 96.4 | 217.8 | 32.2 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 300.57 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.acquisitions-net | -6.67 | -5.2 | -142.9 | -7.8 | ||||||||||||||
cash-flows.row.purchases-of-investments | -73.23 | -191.1 | -8 | -9.1 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 78.46 | 262.4 | 5.4 | 1.3 | ||||||||||||||
cash-flows.row.other-investing-activites | 201.18 | 31.3 | -70.7 | -287.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 103.13 | 102.6 | -216.2 | -336.2 | ||||||||||||||
cash-flows.row.debt-repayment | -297.87 | -112.3 | -81.3 | -767.7 | ||||||||||||||
cash-flows.row.common-stock-issued | -1.49 | -2.7 | -4.8 | 308.7 | ||||||||||||||
cash-flows.row.common-stock-repurchased | -2.68 | -2.7 | -4.8 | -308.7 | ||||||||||||||
cash-flows.row.dividends-paid | -277.45 | -277.4 | -277.2 | -262.9 | ||||||||||||||
cash-flows.row.other-financing-activites | 169.19 | -15.2 | 206.3 | 1060.7 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -410.3 | -410.3 | -161.7 | 30.1 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.61 | -0.6 | 0.3 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -7.21 | -7.2 | -62 | 50.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.64 | 46.7 | 53.9 | 115.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 163.85 | 53.9 | 115.9 | 65.5 | ||||||||||||||
cash-flows.row.operating-cash-flow | 300.57 | 301.1 | 315.7 | 356.4 | ||||||||||||||
cash-flows.row.capital-expenditure | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.free-cash-flow | 203.95 | 306.4 | 315.7 | 322.8 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 648.5 | 655.8 | 624.8 | 569.5 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 238.12 | 378.3 | 162.6 | 141.2 | ||||||||||||||
income-statement-row.row.gross-profit | 410.38 | 277.5 | 462.2 | 428.3 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 47.47 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.operating-expenses | 173.24 | 42.4 | 227.5 | 217.6 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 411.36 | 420.8 | 390.1 | 358.8 | ||||||||||||||
income-statement-row.row.interest-income | 85.02 | 0 | 105.6 | 98.7 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.total-operating-expenses | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
income-statement-row.row.ebitda-caps | 420.66 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 326.36 | 235.1 | 135.6 | 19 | ||||||||||||||
income-statement-row.row.income-before-tax | 15.76 | 7.8 | -76.4 | -111.4 | ||||||||||||||
income-statement-row.row.income-tax-expense | 2 | 2 | 1.2 | 1.8 | ||||||||||||||
income-statement-row.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 |
Biežāk uzdotie jautājumi
Kas ir Sabra Health Care REIT, Inc. (SBRA) kopējie aktīvi?
Sabra Health Care REIT, Inc. (SBRA) kopējie aktīvi ir 5386150000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 326008000.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.633.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.882.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.021.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.503.
Kāda ir Sabra Health Care REIT, Inc. (SBRA) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 13756000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 2446635000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 42446000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 46719000.000.